Back

Risk of bleeding in patients with and without cancer on antiplatelet therapy following myocardial infarction: a study in primary care

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Anticoagulation in cancer Cardio-Oncology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Freek Van Den Berg

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
The impact of cancer on the risk of hospitalisation for bleeding among acute coronary syndrome patients: an analysis of the Virtual Cardio-Oncology Research Initiative (VICORI) database
Doctor K. Ow (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes, mortality, and bleeding in patients with acute myocardial infarction and a history of cancer: a report from the multi-center, nationwide prospective database JAMIR
Doctor A. Adachi (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of cardiovascular events and major bleeding in mortality in patients with atrial fibrillation and active lung cancer: data from a multicentre, retrospective, observational study.
Doctor A. Piserra (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Usefulness of low-dose direct oral anticoagulants for peripheral deep vein thrombosis of the lower extremities in cancer patients with cancer bleeding lesions
Doctor A. Nonaka (Akashi, JP)
Abstract Slides Video
Presentation thumbnail
Age- and sex- specific rate of venous thromboembolism in cancer survivors: a nationwide cohort study
Ms G. Sun (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation in cancer

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources